Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by Composite Physiologic Index (CPI)

被引：0
|
作者：
Nambiar, A. M. [1 ]
Molina-Molina, M. [2 ]
Padilla, M. [3 ]
Song, J. [4 ]
Mueller, H. [5 ]
Stowasser, S. [5 ]
Rohr, K. B. [5 ]
Wells, A. U. [6 ,7 ]
机构：
[1] Univ Texas Hlth San Antonio, Div Pulm & Crit Care Med, Dept Med, San Antonio, TX USA
[2] Univ Hosp Bellvitge, ILD Unit, IDIBELL, Barcelona, Spain
[3] Icahn Sch Med Mt Sinai, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Pulm & Crit Care Med, Seoul, South Korea
[5] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[6] Royal Brompton & Harefield NHS Fdn Trust, Natl Inst Hlth Res, Resp Biomed Res Unit, London, England
[7] Imperial Coll, Natl Heart & Lung Inst, London, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1905
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effects of Nintedanib on Circulating Biomarkers in Subjects with Progressive Fibrosing Interstitial Lung Diseases (ILDs)
    Maher, T. M.
    Jenkins, R. G.
    Bonella, F.
    Assassi, S.
    Diefenbach, C.
    Ittrich, C.
    Rohr, K. B.
    Kolb, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [2] Efficacy and Safety of Nintedanib in Elderly Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs)
    Moua, T.
    Bonella, F.
    Okamoto, M.
    Tomassetti, S.
    Valenzuela, C.
    Wuyts, W.
    Miede, C.
    Lievens, D.
    Bendstrup, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [3] Efficacy and safety of nintedanib in elderly patients with progressive fibrosing interstitial lung diseases (ILDs)*
    Bonella, Autoren F.
    Moua, T.
    Okamoto, M.
    Tomassetti, S.
    Valenzuela, C.
    Wuyts, W.
    Miede, C.
    Lievens, D.
    Bendstrup, E.
    PNEUMOLOGIE, 2023, 77 : S57 - S57
  • [4] Characteristics of Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) in the INBUILD Trial of Nintedanib
    Flaherty, K. R.
    Wells, A. U.
    Clerisme-Beaty, E.
    Cottin, V.
    Devaraj, A.
    Inoue, Y.
    Richeldi, L.
    Walsh, S.
    Goeldner, R.
    Schlenker-Herceg, R.
    Brown, K. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [5] Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) Taking Anti-Acid Therapy
    Kreuter, M.
    Glazer, C.
    Kitamura, H.
    Koschel, D.
    Moua, T.
    Mueller, H.
    Stowasser, S.
    Rohr, K. B.
    Brown, K. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [6] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
    Fabre, Aurelie
    Nicholson, Andrew G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 780 - 780
  • [7] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
    Flaherty, K. R.
    Wells, A. U.
    Cottin, V
    Devaraj, A.
    Walsh, S. L. F.
    Inoue, Y.
    Richeldi, L.
    Kolb, M.
    Tetzlaff, K.
    Stowasser, S.
    Coeck, C.
    Clerisme-Beaty, E.
    Rosenstock, B.
    Quaresma, M.
    Haeufel, T.
    Goeldner, R-G
    Schlenker-Herceg, R.
    Brown, K. K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18): : 1718 - 1727
  • [8] Nintedanib in progressive fibrosing interstitial lung diseases
    Hadjiski, D.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (04): : 393 - 394
  • [9] Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
    Joannes, Audrey
    Voisin, Tom
    Morzadec, Claudie
    Letellier, Alice
    Gutierrez, Francisco Llamas
    Chiforeanu, Dan Cristian
    Le Naoures, Cecile
    Guillot, Stephanie
    De Latour, Bertrand Richard
    Rouze, Simon
    Jaillet, Madeleine
    Crestani, Bruno
    Wollin, Lutz
    Jouneau, Stephanie
    Vernhet, Laurent
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 83
  • [10] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases Reply
    Flaherty, Kevin R.
    Wells, Athol U.
    Brown, Kevin K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 781 - 781
12345